Northern Trust Corp Allovir, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Allovir, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 158,418 shares of ALVR stock, worth $71,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,418

Previous 437,331 63.78%

Holding current value

$71,288

Previous $314,000 59.24%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.7 - $0.82 $195,239 - $228,708	-278,913 Reduced 63.78%	158,418 $128,000
Q2 2024 Aug 14, 2024	SELL	$0.72 - $0.82 $8,743 - $9,958	-12,144 Reduced 2.7%	437,331 $314,000
Q1 2024 May 14, 2024	BUY	$0.64 - $0.78 $12,990 - $15,831	20,297 Added 4.73%	449,475 $341,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $2.39 $31,705 - $111,436	-46,626 Reduced 9.8%	429,178 $291,000
Q3 2023 Nov 13, 2023	SELL	$2.15 - $3.64 $84,608 - $143,244	-39,353 Reduced 7.64%	475,804 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$3.17 - $5.82 $221,728 - $407,085	69,946 Added 15.71%	515,157 $1.75 Million
Q1 2023 May 15, 2023	SELL	$3.94 - $7.05 $57,614 - $103,092	-14,623 Reduced 3.18%	445,211 $1.75 Million
Q4 2022 Feb 13, 2023	BUY	$4.7 - $9.98 $22,602 - $47,993	4,809 Added 1.06%	459,834 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $724,707 - $1.54 Million	175,474 Added 62.77%	455,025 $3.59 Million
Q2 2022 Aug 12, 2022	SELL	$3.26 - $7.06 $16,143 - $34,961	-4,952 Reduced 1.74%	279,551 $1.09 Million
Q1 2022 May 13, 2022	SELL	$6.75 - $13.52 $91,631 - $183,534	-13,575 Reduced 4.55%	284,503 $1.92 Million
Q4 2021 Feb 08, 2022	BUY	$12.94 - $25.99 $35,973 - $72,252	2,780 Added 0.94%	298,078 $3.86 Million
Q3 2021 Nov 15, 2021	BUY	$16.97 - $25.06 $91,960 - $135,800	5,419 Added 1.87%	295,298 $7.4 Million
Q2 2021 Aug 13, 2021	SELL	$19.44 - $25.06 $33,184 - $42,777	-1,707 Reduced 0.59%	289,879 $5.72 Million
Q1 2021 May 12, 2021	BUY	$20.81 - $45.5 $1.63 Million - $3.57 Million	78,429 Added 36.79%	291,586 $6.82 Million
Q4 2020 Feb 11, 2021	SELL	$23.94 - $46.81 $13,669 - $26,728	-571 Reduced 0.27%	213,157 $8.19 Million
Q3 2020 Nov 16, 2020	BUY	$21.05 - $42.7 $4.5 Million - $9.13 Million	213,728 New	213,728 $5.88 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $41.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Allovir, Inc. Transaction History